$VTGN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in VistaGen Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in VistaGen Therapeutics, Inc.. Get notifications about new insider transactions in VistaGen Therapeutics, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 24 2013 | NA | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Option Exercise | A | 0.50 | 100,000 | 50,000 | 100,000 | |
Dec 24 2013 | NA | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Option Exercise | D | 1.93 | 100,000 | 193,000 | 0 | |
Dec 24 2013 | NA | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Option Exercise | A | 0.50 | 250,000 | 125,000 | 250,000 | |
Dec 24 2013 | NA | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Option Exercise | D | 1.50 | 250,000 | 375,000 | 0 | |
Dec 24 2013 | NA | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Option Exercise | A | 0.50 | 150,000 | 75,000 | 150,000 | |
Dec 24 2013 | NA | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Option Exercise | D | 1.65 | 150,000 | 247,500 | 0 | |
Dec 24 2013 | NA | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Option Exercise | A | 0.50 | 25,000 | 12,500 | 25,000 | |
Dec 24 2013 | NA | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Option Exercise | D | 1.13 | 25,000 | 28,250 | 0 | |
Dec 24 2013 | NA | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Option Exercise | A | 0.50 | 50,000 | 25,000 | 50,000 | |
Dec 24 2013 | NA | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Option Exercise | D | 1.13 | 50,000 | 56,500 | 0 | |
Dec 24 2013 | NA | VistaGen Therapeut ... | DOTSON JERROLD DUANE | CFO AND SECRETARY | Option Exercise | A | 0.50 | 1,000 | 500 | 1,000 | |
Dec 24 2013 | NA | VistaGen Therapeut ... | DOTSON JERROLD DUANE | CFO AND SECRETARY | Option Exercise | D | 2.10 | 1,000 | 2,100 | 0 | |
Dec 24 2013 | NA | VistaGen Therapeut ... | DOTSON JERROLD DUANE | CFO AND SECRETARY | Option Exercise | A | 0.50 | 6,251 | 3,126 | 6,251 | |
Dec 24 2013 | NA | VistaGen Therapeut ... | DOTSON JERROLD DUANE | CFO AND SECRETARY | Option Exercise | D | 0.75 | 6,251 | 4,688 | 0 | |
Dec 24 2013 | NA | VistaGen Therapeut ... | DOTSON JERROLD DUANE | CFO AND SECRETARY | Option Exercise | A | 0.50 | 6,249 | 3,125 | 6,249 | |
Dec 24 2013 | NA | VistaGen Therapeut ... | DOTSON JERROLD DUANE | CFO AND SECRETARY | Option Exercise | D | 0.75 | 6,249 | 4,687 | 0 | |
Dec 24 2013 | NA | VistaGen Therapeut ... | DOTSON JERROLD DUANE | CFO AND SECRETARY | Option Exercise | A | 0.50 | 86,459 | 43,230 | 86,459 | |
Dec 24 2013 | NA | VistaGen Therapeut ... | DOTSON JERROLD DUANE | CFO AND SECRETARY | Option Exercise | D | 0.75 | 86,459 | 64,844 | 0 | |
Dec 24 2013 | NA | VistaGen Therapeut ... | DOTSON JERROLD DUANE | CFO AND SECRETARY | Option Exercise | A | 0.50 | 13,541 | 6,771 | 13,541 | |
Dec 24 2013 | NA | VistaGen Therapeut ... | DOTSON JERROLD DUANE | CFO AND SECRETARY | Option Exercise | D | 0.75 | 13,541 | 10,156 | 0 | |
Dec 24 2013 | NA | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 1.00 | 100,000 | 100,000 | 100,000 | |
Dec 24 2013 | NA | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 0.50 | 80,338 | 40,169 | 80,338 | |
Dec 24 2013 | NA | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | D | 1.75 | 80,338 | 140,592 | 0 | |
Dec 24 2013 | NA | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 0.50 | 50,000 | 25,000 | 50,000 | |
Dec 24 2013 | NA | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | D | 1.50 | 50,000 | 75,000 | 0 | |
Dec 24 2013 | NA | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 0.50 | 35,714 | 17,857 | 35,714 | |
Dec 24 2013 | NA | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | D | 1.75 | 35,714 | 62,500 | 0 | |
Dec 24 2013 | NA | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 0.50 | 40,000 | 20,000 | 40,000 | |
Dec 24 2013 | NA | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | D | 2.10 | 40,000 | 84,000 | 0 | |
Dec 24 2013 | NA | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 0.50 | 100,000 | 50,000 | 100,000 | |
Dec 24 2013 | NA | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | D | 1.75 | 100,000 | 175,000 | 0 | |
Dec 24 2013 | NA | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 0.50 | 425,000 | 212,500 | 425,000 | |
Dec 24 2013 | NA | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | D | 1.50 | 425,000 | 637,500 | 0 | |
Dec 24 2013 | NA | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 0.50 | 1,000,000 | 500,000 | 1,000,000 | |
Dec 24 2013 | NA | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | D | 1.50 | 1,000,000 | 1,500,000 | 0 | |
Dec 24 2013 | NA | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 0.50 | 22,500 | 11,250 | 22,500 | |
Dec 24 2013 | NA | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | D | 1.13 | 22,500 | 25,425 | 0 | |
Dec 24 2013 | NA | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 0.50 | 60,000 | 30,000 | 60,000 | |
Dec 24 2013 | NA | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | D | 1.13 | 60,000 | 67,800 | 0 | |
Dec 24 2013 | NA | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Grant | A | 0.00 | 100,000 | 0 | 100,000 | 0 to 100 K |
Oct 29 2013 | NA | VistaGen Therapeut ... | DOTSON JERROLD DUANE | CFO AND SECRETARY | Option Exercise | A | 0.40 | 20,000 | 8,000 | 20,000 | |
Oct 15 2013 | NA | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | M | 0.64 | 10,000 | 6,400 | 1,440,000 | |
Oct 15 2013 | NA | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Buy | M | 0.64 | 10,000 | 6,400 | 312,174 | 302.2 K to 312.2 K (+3.31 %) |
Jun 27 2013 | NA | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | M | 0.64 | 50,000 | 32,000 | 1,450,000 | |
Jun 27 2013 | NA | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Buy | M | 0.64 | 50,000 | 32,000 | 302,174 | 252.2 K to 302.2 K (+19.83 %) |
Mar 06 2013 | NA | VistaGen Therapeut ... | SAXE JON S | Option Exercise | J | 0.64 | 150,000 | 96,000 | 150,000 | ||
Mar 05 2013 | NA | VistaGen Therapeut ... | Underdown Brian J. | Option Exercise | J | 0.64 | 150,000 | 96,000 | 150,000 | ||
Mar 05 2013 | NA | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Option Exercise | J | 0.64 | 1,000,000 | 640,000 | 1,000,000 | |
Mar 05 2013 | NA | VistaGen Therapeut ... | DOTSON JERROLD DUANE | CFO | Option Exercise | J | 0.64 | 200,000 | 128,000 | 200,000 | |
Mar 05 2013 | NA | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | J | 0.64 | 1,500,000 | 960,000 | 1,500,000 | |
Dec 06 2012 | NA | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 1.50 | 50,000 | 75,000 | 50,000 | |
Dec 06 2012 | NA | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Grant | A | 0.50 | 100,000 | 50,000 | 252,174 | 152.2 K to 252.2 K (+65.71 %) |
Nov 01 2012 | NA | VistaGen Therapeut ... | DOTSON JERROLD DUANE | CFO | Option Exercise | A | 0.75 | 12,500 | 9,375 | 12,500 | |
Nov 01 2012 | NA | VistaGen Therapeut ... | DOTSON JERROLD DUANE | CFO | Option Exercise | D | 1.75 | 10,000 | 17,500 | 0 | |
Nov 01 2012 | NA | VistaGen Therapeut ... | DOTSON JERROLD DUANE | CFO | Option Exercise | D | 1.13 | 2,500 | 2,825 | 0 | |
Nov 01 2012 | NA | VistaGen Therapeut ... | DOTSON JERROLD DUANE | CFO | Option Exercise | A | 0.75 | 100,000 | 75,000 | 100,000 | |
Nov 01 2012 | NA | VistaGen Therapeut ... | DOTSON JERROLD DUANE | CFO | Option Exercise | D | 2.58 | 50,000 | 129,000 | 0 | |
May 07 2012 | NA | VistaGen Therapeut ... | RICE A. FRANKLIN | VP CORPORATE DEVELO ... | Gift | G | 0.00 | 50,000 | 0 | 174,046 | 224 K to 174 K (-22.32 %) |
Feb 15 2012 | NA | VistaGen Therapeut ... | Bonfiglio Gregory A. | Option Exercise | A | 3.00 | 50,000 | 150,000 | 50,000 | ||
Feb 15 2012 | NA | VistaGen Therapeut ... | SAXE JON S | Option Exercise | A | 3.00 | 50,000 | 150,000 | 0 | ||
Feb 15 2012 | NA | VistaGen Therapeut ... | Underdown Brian J. | Option Exercise | A | 3.00 | 50,000 | 150,000 | 50,000 | ||
Jan 09 2012 | NA | VistaGen Therapeut ... | Cato Allen Easley | 10% Owner | Option Exercise | X | 2.00 | 162,500 | 325,000 | 0 | |
Jan 09 2012 | NA | VistaGen Therapeut ... | Cato Allen Easley | 10% Owner | Option Exercise | X | 1.75 | 46,542 | 81,449 | 0 | |
Jan 09 2012 | NA | VistaGen Therapeut ... | Cato Allen Easley | 10% Owner | Option Exercise | X | 2.10 | 2,916 | 6,124 | 0 | |
Jan 09 2012 | NA | VistaGen Therapeut ... | Cato Allen Easley | 10% Owner | Option Exercise | X | 2.50 | 212,166 | 530,415 | 0 | |
Jan 09 2012 | NA | VistaGen Therapeut ... | Cato Allen Easley | 10% Owner | Option Exercise | S | 1.75 | 6,988 | 12,229 | 28,067 | |
Jan 09 2012 | NA | VistaGen Therapeut ... | Cato Allen Easley | 10% Owner | Option Exercise | X | 1.75 | 11,363 | 19,885 | 28,067 | |
Jan 09 2012 | NA | VistaGen Therapeut ... | Cato Allen Easley | 10% Owner | Buy | C | 9,999.44 | 11,363 | 113,623,637 | 28,497 | 17.1 K to 28.5 K (+66.32 %) |
Jan 09 2012 | NA | VistaGen Therapeut ... | CATO HOLDING CO | 10% Owner | Option Exercise | C | 162,500.00 | 162,500 | 26,406,250,000 | 0 | |
Jan 09 2012 | NA | VistaGen Therapeut ... | CATO HOLDING CO | 10% Owner | Option Exercise | C | 40,957.00 | 46,542 | 1,906,218,832 | 0 | |
Jan 09 2012 | NA | VistaGen Therapeut ... | CATO HOLDING CO | 10% Owner | Option Exercise | C | 3,061.80 | 2,916 | 8,928,209 | 0 | |
Jan 09 2012 | NA | VistaGen Therapeut ... | CATO HOLDING CO | 10% Owner | Option Exercise | C | 265,208.00 | 212,166 | 56,268,014,445 | 0 | |
Jan 09 2012 | NA | VistaGen Therapeut ... | CATO HOLDING CO | 10% Owner | Buy | C | 471,727.00 | 424,124 | 200,070,852,420 | 3,310,836 | 2.9 M to 3.3 M (+14.69 %) |
Dec 23 2011 | NA | VistaGen Therapeut ... | RICE A. FRANKLIN | CHIEF OPERATING OFF ... | Gift | G | 0.00 | 16,000 | 0 | 224,046 | 240 K to 224 K (-6.67 %) |
Dec 23 2011 | NA | VistaGen Therapeut ... | RICE A. FRANKLIN | CHIEF OPERATING OFF ... | Gift | G | 0.00 | 219,000 | 0 | 240,046 | 459 K to 240 K (-47.71 %) |
Dec 23 2011 | NA | VistaGen Therapeut ... | Platinum Long Term Growth VII, ... | 10% Owner | Option Exercise | J | 0.00 | 45,980 | 0 | 459,800 | |
Dec 23 2011 | NA | VistaGen Therapeut ... | Platinum Long Term Growth VII, ... | 10% Owner | Sell | J | 0.00 | 484,000 | 0 | 1,558,862 | 2 M to 1.6 M (-23.69 %) |
Dec 22 2011 | NA | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Option Exercise | M | 0.88 | 113,636 | 100,000 | 0 | |
Dec 22 2011 | NA | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Buy | M | 0.88 | 113,636 | 100,000 | 1,204,468 | 1.1 M to 1.2 M (+10.42 %) |
Dec 16 2011 | NA | VistaGen Therapeut ... | SAXE JON S | Option Exercise | X | 1.25 | 2,784 | 3,480 | 0 | ||
Dec 16 2011 | NA | VistaGen Therapeut ... | SAXE JON S | Buy | X | 1.25 | 2,784 | 3,480 | 20,138 | 17.4 K to 20.1 K (+16.04 %) | |
Sep 20 2011 | NA | VistaGen Therapeut ... | DOTSON JERROLD DUANE | ACTING CFO | Option Exercise | A | 2.55 | 50,000 | 127,500 | 50,000 | |
Jun 03 2011 | NA | VistaGen Therapeut ... | JONES STEPHANIE | PRESIDENT | Sell | S | 0.00 | 4,982,103 | 0 | 17,897 | 5 M to 17.9 K (-99.64 %) |
May 25 2011 | NA | VistaGen Therapeut ... | SAXE JON S | Option Exercise | A | 5.00 | 1,392 | 6,960 | 1,392 | ||
May 25 2011 | NA | VistaGen Therapeut ... | SAXE JON S | Option Exercise | A | 3.50 | 25,000 | 87,500 | 25,000 | ||
May 25 2011 | NA | VistaGen Therapeut ... | SAXE JON S | Option Exercise | A | 3.00 | 75,000 | 225,000 | 75,000 | ||
May 25 2011 | NA | VistaGen Therapeut ... | SAXE JON S | Option Exercise | A | 3.00 | 10,000 | 30,000 | 10,000 | ||
May 25 2011 | NA | VistaGen Therapeut ... | SAXE JON S | Option Exercise | A | 2.26 | 3,750 | 8,475 | 3,750 | ||
May 25 2011 | NA | VistaGen Therapeut ... | SAXE JON S | Option Exercise | A | 4.20 | 5,000 | 21,000 | 5,000 | ||
May 25 2011 | NA | VistaGen Therapeut ... | SAXE JON S | Option Exercise | A | 1.76 | 3,750 | 6,600 | 3,750 | ||
May 25 2011 | NA | VistaGen Therapeut ... | SAXE JON S | Option Exercise | A | 1.72 | 2,500 | 4,300 | 2,500 | ||
May 25 2011 | NA | VistaGen Therapeut ... | SAXE JON S | Option Exercise | A | 1.60 | 3,000 | 4,800 | 3,000 | ||
May 25 2011 | NA | VistaGen Therapeut ... | SAXE JON S | Option Exercise | A | 1.60 | 4,375 | 7,000 | 4,375 | ||
May 25 2011 | NA | VistaGen Therapeut ... | SAXE JON S | Option Exercise | A | 1.60 | 1,250 | 2,000 | 1,250 | ||
May 25 2011 | NA | VistaGen Therapeut ... | SAXE JON S | Option Exercise | A | 1.60 | 5,000 | 8,000 | 5,000 | ||
May 25 2011 | NA | VistaGen Therapeut ... | SAXE JON S | Grant | A | 3.50 | 17,354 | 60,739 | 17,354 | 0 to 17.4 K | |
May 25 2011 | NA | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Option Exercise | A | 3.85 | 50,000 | 192,500 | 50,000 | |
May 25 2011 | NA | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Option Exercise | A | 3.00 | 125,000 | 375,000 | 125,000 | |
May 25 2011 | NA | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Option Exercise | A | 3.00 | 75,000 | 225,000 | 75,000 | |
May 25 2011 | NA | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Option Exercise | A | 2.26 | 12,500 | 28,250 | 12,500 | |
May 25 2011 | NA | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Option Exercise | A | 2.26 | 25,000 | 56,500 | 25,000 | |
May 25 2011 | NA | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Option Exercise | A | 4.62 | 12,500 | 57,750 | 12,500 | |
May 25 2011 | NA | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Option Exercise | A | 1.58 | 20,000 | 31,600 | 20,000 | |
May 25 2011 | NA | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Option Exercise | A | 1.76 | 3,181 | 5,599 | 3,181 | |
May 25 2011 | NA | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Option Exercise | A | 1.76 | 56,818 | 100,000 | 56,818 | |
May 25 2011 | NA | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Grant | A | 3.50 | 545,416 | 1,908,956 | 545,416 | 0 to 545.4 K |
May 25 2011 | NA | VistaGen Therapeut ... | RICE A. FRANKLIN | CHIEF FINANCIAL OFF ... | Option Exercise | A | 5.00 | 795 | 3,975 | 795 | |
May 25 2011 | NA | VistaGen Therapeut ... | RICE A. FRANKLIN | CHIEF FINANCIAL OFF ... | Option Exercise | A | 3.50 | 50,000 | 175,000 | 50,000 | |
May 25 2011 | NA | VistaGen Therapeut ... | RICE A. FRANKLIN | CHIEF FINANCIAL OFF ... | Option Exercise | A | 3.00 | 87,500 | 262,500 | 87,500 | |
May 25 2011 | NA | VistaGen Therapeut ... | RICE A. FRANKLIN | CHIEF FINANCIAL OFF ... | Option Exercise | A | 3.00 | 50,000 | 150,000 | 50,000 | |
May 25 2011 | NA | VistaGen Therapeut ... | RICE A. FRANKLIN | CHIEF FINANCIAL OFF ... | Option Exercise | A | 2.26 | 10,000 | 22,600 | 10,000 | |
May 25 2011 | NA | VistaGen Therapeut ... | RICE A. FRANKLIN | CHIEF FINANCIAL OFF ... | Option Exercise | A | 2.26 | 20,000 | 45,200 | 20,000 | |
May 25 2011 | NA | VistaGen Therapeut ... | RICE A. FRANKLIN | CHIEF FINANCIAL OFF ... | Option Exercise | A | 4.20 | 12,500 | 52,500 | 12,500 | |
May 25 2011 | NA | VistaGen Therapeut ... | RICE A. FRANKLIN | CHIEF FINANCIAL OFF ... | Option Exercise | A | 1.44 | 10,000 | 14,400 | 10,000 | |
May 25 2011 | NA | VistaGen Therapeut ... | RICE A. FRANKLIN | CHIEF FINANCIAL OFF ... | Option Exercise | A | 1.60 | 32,500 | 52,000 | 32,500 | |
May 25 2011 | NA | VistaGen Therapeut ... | RICE A. FRANKLIN | CHIEF FINANCIAL OFF ... | Option Exercise | A | 1.76 | 6,250 | 11,000 | 6,250 | |
May 25 2011 | NA | VistaGen Therapeut ... | RICE A. FRANKLIN | CHIEF FINANCIAL OFF ... | Option Exercise | A | 1.90 | 5,500 | 10,450 | 5,500 | |
May 25 2011 | NA | VistaGen Therapeut ... | RICE A. FRANKLIN | CHIEF FINANCIAL OFF ... | Option Exercise | A | 5.25 | 1,428 | 7,497 | 1,428 | |
May 25 2011 | NA | VistaGen Therapeut ... | RICE A. FRANKLIN | CHIEF FINANCIAL OFF ... | Grant | A | 3.50 | 229,521 | 803,324 | 229,521 | 0 to 229.5 K |
May 25 2011 | NA | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 3.50 | 17,857 | 62,500 | 17,857 | |
May 25 2011 | NA | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 3.50 | 40,169 | 140,592 | 40,169 | |
May 25 2011 | NA | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 1.44 | 20,000 | 28,800 | 20,000 | |
May 25 2011 | NA | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 1.60 | 10,000 | 16,000 | 10,000 | |
May 25 2011 | NA | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 3.50 | 750 | 2,625 | 750 | |
May 25 2011 | NA | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 3.50 | 50,000 | 175,000 | 50,000 | |
May 25 2011 | NA | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 3.00 | 212,500 | 637,500 | 212,500 | |
May 25 2011 | NA | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 3.00 | 500,000 | 1,500,000 | 500,000 | |
May 25 2011 | NA | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 2.26 | 11,250 | 25,425 | 11,250 | |
May 25 2011 | NA | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 2.26 | 30,000 | 67,800 | 30,000 | |
May 25 2011 | NA | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 4.20 | 10,000 | 42,000 | 10,000 | |
May 25 2011 | NA | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 4.20 | 10,000 | 42,000 | 10,000 | |
May 25 2011 | NA | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Grant | A | 3.50 | 76,087 | 266,305 | 76,087 | 0 to 76.1 K |